Plurogen Therapeutics
Norristown, US
Find your way into Plurogen Therapeutics
Sign up to see every warm intro you have to Plurogen Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Plurogen Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
GT
George T. RodeheaverCo-founder
AJ
Adam J. KatzCo-founder
NG
Neal G. KollerExecutive
Board
JB
James B. FarinholtBoard director
DB
Daniel BrodyBoard director
WL
Wendy L. YarnoBoard director
Reported raises · per SEC filings
Form D private placements$453.2K disclosed across 2 rounds · 2013–2014
▶$153.2KraisedApr 2014 · 3 investors · BiotechnologyRule 506(b)
▶$153.2KraisedApr 2014 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Neal G KollerExecutive Officer, Director
- Adam J. KatzExecutive Officer, Director
- James B. FarinholtDirector
- Daniel BrodyDirector
- George T. RodeheaverExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $153.2K
- Minimum investment
- $5K
- Proceeds to insiders
- $200K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KraisedJan 2014 · 4 investors · BiotechnologyRule 506(b)
▶$300KraisedJan 2014 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel BrodyDirector
- Wendy L. YarnoDirector
- James B. FarinholtDirector
- George T. RodeheaverExecutive Officer, Director
- Neal G. KollerExecutive Officer, Director
- Adam J. KatzExecutive Officer, Director
- Offering amount
- $4.1M
- Amount sold
- $300K
- Minimum investment
- $50K
- Proceeds to insiders
- $750K
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Plurogen Therapeutics?
- Plurogen Therapeutics was founded by George T. Rodeheaver, Adam J. Katz.
- How much funding has Plurogen Therapeutics raised?
- Plurogen Therapeutics has disclosed $453.2K raised across 2 rounds.
- Where is Plurogen Therapeutics headquartered?
- Plurogen Therapeutics is headquartered in Norristown, US.